Prominent Silicon Valley Intellectual Property Partner Joins Paul Hastings

Paul Hastings LLP, a leading global law firm, announced today that Chris Kennerly, has joined the firm as a partner with the Intellectual Property practice in Palo Alto. Mr. Kennerly joins from Baker Botts LLP, where he was chair of the Palo Alto IP department. His technology-based practice and experience with mobile telecom companies complements the firms growing footprint in the mobile technology market.

More >>

Tags:  Paul Hastings, LLP | Silicon Valley

Paul Hastings Represents JPMorgan in Connection with Increase and Extension of $2 Billion Credit Facility for Murphy Oil Corporation

Paul Hastings LLP, a leading global law firm, announced today that the firm represented J.P. Morgan Securities LLC, Merrill Lynch, Pierce, Fenner & Smith Incorporated, DNB Markets, Inc., RBC Capital Markets and Wells Fargo Securities, LLC, as co-lead arrangers and joint bookrunners, and JPMorgan Chase Bank, N.A., as the administrative agent, in connection with a commitment increase and maturity date extension for the $2 billion revolving credit facility for Murphy Oil Corporation, Canam Offshore Limited and Murphy Oil Company Ltd.

More >>

Tags:  Paul Hastings, LLP | Houston

Paul Hastings Represents Shuanghui International Holdings Limited in US $7.1 Billion Acquisition of Smithfield Foods

Paul Hastings, a leading global law firm, announced today that the firm is representing Shuanghui International Holdings Limited, the owner of China’s largest publicly-traded meat processing enterprise, in a US$7.1 billion agreement to acquire Smithfield Foods, Inc. (NYSE: SFD), the largest U.S. publicly-traded pork processor and hog producer. The combination will create one of the largest global pork production, processing and packaged meat companies in the world.

More >>

Tags:  Paul Hastings, LLP | Hong Kong

Davis Polk Advises AstraZeneca on Its Acquisition of Omthera Pharmaceuticals

Davis Polk is advising AstraZeneca PLC in connection with its acquisition of Omthera Pharmaceuticals, Inc. The closing of the transaction, which is subject to the approval of Omthera’s shareholders as well as other customary closing conditions, is expected to occur in the third quarter of 2013. Under the terms of the merger agreement, AstraZeneca will acquire Omthera for up to approximately $443 million, comprised of an upfront payment of approximately $323 million and contractual “contingent value rights” entitling the holders to receive up to $120 million upon the achievement of specified milestones related to Epanova™, Omthera’s investigational product.

More >>

Tags:  Davis Polk & Wardwell LLP | New York

Davis Polk – Fidelity National Financial Acquires Lender Processing Services

Davis Polk is advising Bank of America Merrill Lynch and J.P. Morgan Securities LLC as financial advisers to Fidelity National Financial, Inc. in connection with its $2.9 billion acquisition of Lender Processing Services, Inc. The transaction, which is subject to approval by LPS and FNF stockholders and other customary closing conditions, is expected to close in the fourth quarter of 2013.

More >>

Tags:  Davis Polk & Wardwell LLP | New York